In our own previous work, we have investigated the enrichment of somatic mutations, abnormal methylation and copy number alterations in the proximity of active CTCF binding sites at the boundaries of topologically associated domains (TADs) in 26 cancer types (14), and developed a theoretical, mathematical framework to predict the impact of different mutational processes on binding sites of specific transcription factors (8). This evidence concerns the gene CTCF and cancer.